Fractionated doses of radioiodine for ablation of postsurgical thyroid tissue remnants
Journal Article
·
· Clinical Nuclear Medicine; (USA)
- Univ. of Rochester Medical Center, NY (USA)
Patients who have differentiated thyroid carcinoma and have undergone total thyroidectomy are treated with radioiodine for ablation of functional thyroid remnants. Administration of a single therapeutic dose in excess of 30 mCi of l-131 requires hospitalization. In an attempt to obviate the necessity for hospitalization, the prospective ablative dose was divided into two or three fractions given at weekly intervals on an ambulatory basis. To assess the effectiveness of this approach, this group of patients was compared to a cohort of hospitalized patients treated with a single dose. Ablation was achieved in 9 out of 12 patients treated in a fractionated manner (a 75% success rate), whereas in 16 out of 20 patients given a single dose the thyroid remnants were completely eradicated (an 80% success rate). That the use of split, smaller doses administered at weekly intervals on an ambulatory basis presents a reasonable alternative for ablation of postsurgical, residual-functioning thyroid tissue.
- OSTI ID:
- 6272776
- Journal Information:
- Clinical Nuclear Medicine; (USA), Journal Name: Clinical Nuclear Medicine; (USA) Vol. 15:10; ISSN CNMED; ISSN 0363-9762
- Country of Publication:
- United States
- Language:
- English
Similar Records
Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients
Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Journal Article
·
Thu Oct 31 23:00:00 EST 1985
· Clin. Nucl. Med.; (United States)
·
OSTI ID:5942827
Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Journal Article
·
Tue Mar 31 23:00:00 EST 1981
· Clin. Nucl. Med.; (United States)
·
OSTI ID:5503856
Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Journal Article
·
Tue Mar 31 23:00:00 EST 1981
· Clin. Nucl. Med.; (United States)
·
OSTI ID:5794828
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ENDOCRINE GLANDS
FRACTIONATED IRRADIATION
GLANDS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
IRRADIATION
ISOTOPES
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
RADIATION DOSES
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SURGERY
THERAPY
THYROID
THYROIDECTOMY
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ENDOCRINE GLANDS
FRACTIONATED IRRADIATION
GLANDS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
IRRADIATION
ISOTOPES
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
RADIATION DOSES
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SURGERY
THERAPY
THYROID
THYROIDECTOMY